Title of work: MTS Spark Waves® – a new regenerative therapy for paraplegia
MTS Spark Waves® is a type of regenerative therapy that combines extracorporeal shock wave therapy (ESWT) and mechanotransduction to stimulate the body’s natural healing processes at the cellular level. ESWT is a widely used treatment that can activate cellular signaling molecules, which stimulate the blood circulation of affected tissues. Shock waves have been found to induce the proliferation and migration of cells, have anti-apoptotic, anti-inflammatory, and analgesic effects, making it an ideal treatment for wound healing, orthopedics, and erectile dysfunction.
Studies have shown that MTS Spark Waves® have a positive effect on neuronal regeneration, specifically on the expression of growth factors like VEGF (vascular endothelial growth factor) and its associated receptor VEGF-R2. VEGF has been found to exert a neuroprotective effect and prevent secondary damage to neural tissue after spinal cord injury. Furthermore, increased expression of VEGF and an improvement in tissue vascularization by ESWT represent promising treatment approach. Recent research on rats has shown that MTS Spark Waves® stimulates VEGF expression and angiogenesis after spinal cord injury, leading to improved restoration of motor and sensory function. The use of low-energy shock waves in this treatment has also been found to not cause nerve tissue damage.
In conclusion, MTS Spark Waves® therapy could be a promising new treatment approach for those suffering from paraplegia. By stimulating the expression of VEGF and reducing secondary damage to injured nerve tissue, this therapy has the potential to improve the restoration of motor function and sensory function. It can become a valuable therapeutic strategy in everyday clinical practice, helping to support the treatment of spinal cord injuries.
Click to read more.